Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors.

@article{Hwang2009PreclinicalIV,
  title={Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors.},
  author={Joo Ha Hwang and Yak-Nam Wang and Cinderella Warren and Melissa P. Upton and Frank L. Starr and Yufeng Zhou and Stuart B. Mitchell},
  journal={Ultrasound in medicine & biology},
  year={2009},
  volume={35 6},
  pages={
          967-75
        }
}
Extracorporeal high-intensity focused ultrasound (HIFU) can be used to ablate tissue noninvasively by delivering focused ultrasound energy from an external source. HIFU for clinical treatment of pancreatic cancer has been reported; however, systematic evaluation of the safety and efficacy of pancreatic ablation with HIFU has not been performed. The objectives of this in vivo study are as follows: (1) assess the safety and feasibility of targeting and ablating pancreatic tissue using the FEP… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

Supportive care: Symptom management

  • SK Reddy, A Elsayem, R. Talukdar
  • Sudbury, England: Jones and Bartlett;
  • 2005
1 Excerpt

A clinical study of thermotherapy of HIFU in combination with chemotherapy on treating advanced pancreatic cancer

  • RS Wang, QX Mu, LX Liu, YQ. Shu
  • Acta Nanjing Med
  • 2003
1 Excerpt

A multicenter nonrandomized clinical study of high intensity focused ultrasound in treating patients with local advanced pancreatic carcinoma

  • DR Xie, D Chen, H. Teng
  • Chin J Clin Oncol
  • 2003
1 Excerpt

Similar Papers

Loading similar papers…